Teva Pharmaceutical Industries Limited American Depositary Shares

TEVA 
(NYSE) 
 
$ 7.680 <%= Resources.Global.txtDown %>
Updated 22/07/2019
Change % -0.13% Stock price decreasing
Change -0.01 Stock price decreasing
Volume 2,864,920
High $ 7.870
Low $ 7.620
Open $ 7.650
ISIN
Prev close $ 7.690
# of shares 920.05M
Market cap 7,065.95M USD
Intraday

Market closed
Teva Pharmaceutical Industries
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  7.68 -5.3% Stock price decreasing -6.9% Stock price decreasing -48.8% Stock price decreasing -60.3% Stock price decreasing -66.9% Stock price decreasing
Powered by TradingView

News about Teva Pharmaceutical Industries

  • English
  • Regulatory news
22 Jul
 
20 Jul
 
19 Jul
 
18 Jul
 
18 Jul
 
18 Jul
 
17 Jul
 
16 Jul
 
16 Jul
 
16 Jul
 

Company profile

Headquartered in Israel, Teva Pharmaceutical is the largest generic drug manufacturer in the world with more than 60 manufacturing and R&D facilities. The company was formed in 1901 and has a portfolio of more than 3,500 medicines--roughly one out of nine generic prescriptions in the U.S. is filled with a Teva product. The company also develops branded pharmaceuticals in the central nervous system, oncology, and respiratory categories. Teva's generic drug sales represent about half of total revenue, with branded drug and distribution revenue making up the balance. Teva is an aggressive filer to bring generic drugs to market when brand patents expire and has the most generic products pending FDA approval.

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
23 July 2019 23:49:55
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190703.1 - EUROWEB1 - 2019-07-24 00:49:55 - 2019-07-23 23:49:55 - 1000 - Website: OKAY